Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 58 entries
View as:

First in Man Clinical Trial of Emodepside (BAY 44-4400)

Phase: N/A Priority: Normal
NCT ID: NCT02661178 Org: User:
Start: 12/31/15 End: 03/27/17 Due: 03/27/18

Bioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market Formulation

Phase: N/A Priority: Normal
NCT ID: NCT02571062 Org: User:
Start: 03/31/15 End: 06/30/15 Due: 06/30/16

Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158

Phase: N/A Priority: Normal
NCT ID: NCT01533961 Org: User:
Start: 02/29/12 End: 03/31/15 Due: 03/31/16

Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT05433350 Org: User:
Start: 07/15/22 End: 03/31/26 Due: 03/31/27

Optimization of PCR Technique to Assess Parasitological Response for Patients With Chronic Chagas Disease

Phase: N/A Priority: Normal
NCT ID: NCT01678599 Org: User:
Start: 04/30/11 End: 04/30/13 Due: 04/30/14

Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.

Phase: N/A Priority: Normal
NCT ID: NCT02011958 Org: User:
Start: 07/31/14 End: 09/15/17 Due: 09/15/18

Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis

Phase: N/A Priority: Normal
NCT ID: NCT00255567 Org: User:
Start: 11/30/04 End: 01/31/10 Due: 01/31/11

Prospective Study of Lopinavir Based ART for HIV Infected childreN Globally (LIVING Study)

Phase: N/A Priority: Normal
NCT ID: NCT02346487 Org: User:
Start: 09/30/15 End: 05/14/19 Due: 05/14/20

Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase

Phase: N/A Priority: Normal
NCT ID: NCT00906880 Org: User:
Start: 04/30/09 End: 01/31/13 Due: 01/31/14

Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa

Phase: N/A Priority: Normal
NCT ID: NCT02431143 Org: User:
Start: 05/31/15 End: 09/30/16 Due: 09/30/17

NeoAMR Observational Study in Neonatal Sepsis

Phase: N/A Priority: Normal
NCT ID: NCT03721302 Org: User:
Start: 08/16/18 End: 02/29/20 Due: 02/28/21

Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis

Phase: N/A Priority: Normal
NCT ID: NCT00146627 Org: User:
Start: - End: 06/30/08 Due: 06/30/09

Mycetoma Retrospective Data Collection

Phase: N/A Priority: Normal
NCT ID: NCT06512714 Org: User:
Start: 06/20/24 End: 08/31/24 Due: 08/31/25

Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa

Phase: N/A Priority: Normal
NCT ID: NCT03129646 Org: User:
Start: 01/24/18 End: 12/11/20 Due: 12/11/21

Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense

Phase: N/A Priority: Normal
NCT ID: NCT03974178 Org: User:
Start: 09/29/19 End: 10/12/22 Due: 10/12/23

Relative Bioavailability Study of Emodepside IR-tablets and Solution

Phase: N/A Priority: Normal
NCT ID: NCT03383523 Org: User:
Start: 10/26/17 End: 03/26/18 Due: 03/26/19

Pharmacokinetic Drug-Drug Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT03892213 Org: User:
Start: 10/31/14 End: 01/31/15 Due: 01/31/16

DDI Study of Single Oral Dose of Acoziborole With Sequential Co-administration of Midazolam and Dextromethorphan

Phase: N/A Priority: Normal
NCT ID: NCT05947604 Org: User:
Start: 02/09/23 End: 05/03/23 Due: 05/03/24

A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR).

Phase: N/A Priority: Normal
NCT ID: NCT06997159 Org: User:
Start: 11/16/25 End: 07/10/27 Due: 07/10/28

Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis

Phase: N/A Priority: Normal
NCT ID: NCT00257530 Org: User:
Start: 12/31/05 End: 06/30/06 Due: 06/30/07

Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan

Phase: N/A Priority: Normal
NCT ID: NCT01980199 Org: User:
Start: 11/30/13 End: 09/30/15 Due: 09/30/16

Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia

Phase: N/A Priority: Normal
NCT ID: NCT01845727 Org: User:
Start: 02/28/14 End: 07/31/16 Due: 07/31/17

Stop Transmission of Gambiense Human African Trypanosomiasis (STROgHAT)

Phase: N/A Priority: Normal
NCT ID: NCT06356974 Org: User:
Start: 04/08/24 End: 12/30/27 Due: 12/30/28

Study to Investigate Effect of Food and Safety of a New Formulation of Zoliflodacin

Phase: N/A Priority: Normal
NCT ID: NCT03718806 Org: User:
Start: 10/03/18 End: 11/12/18 Due: 11/12/19

Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03929016 Org: User:
Start: 04/04/19 End: 07/02/20 Due: 07/02/21